glp-1 requirements for insurance coverage There was a lot of conversation about Medicare and medications last week, and I understand why. so many people, the biggest barrier to evidence-based treatment has never been lack of No Insurance? No Problem! Willow’s
Description
In all five clinical trials (SURPASS trials), Tirzepatide was the only medication to lower body weight (5.411.7 kg) in T2D when given weekly at doses of 515 mg [298]
These findings are constrained by limited sample diversity, variability in outcome measures and the consistent underrepresentation of individuals with psychiatric comorbidities, factors that warrant targeted future research

Despite this, payers remain conflicted on whether pharmaceutical treatment for obesity should be covered

Diabetologia 55: 24452455, 2012
A 6 mL supply costs between $442.97 and $442.98, making it more expensive than metformin but still a cheaper alternative to GLP-1 drugs like Wegovy
